{
    "clinical_study": {
        "@rank": "104172", 
        "acronym": "NINAVAPed", 
        "brief_summary": {
            "textblock": "This pilot study will be an observational no randomize study in which the NiNAVAped protocol\n      will be applied solely to the NIV NAVA arm."
        }, 
        "brief_title": "NIV NAVA Versus NIV-PS in Pediatric Patients - Pilot Study", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Respiratory Failure", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Adult", 
                "Respiratory Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "This pilot study will be an observational no randomize study in which the NiNAVAped protocol\n      will be applied solely to the NIV NAVA arm.\n\n      Every PICU will have to include 3 patients in the Pilot study before starting the clinical\n      trial, which means that the pilot study will involve a maximum of 60 patients.\n\n      Should the Pilot study reveal deficiencies in the NiNAVAped design, the protocol would be\n      improved accordingly.\n\n      There will be a specific consent document during the Pilot study. The Pilot study will be\n      published in a scientific journal."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: > 1 month age to 18 years\n\n          -  Moderate/severe Pediatric Acute Respiratory failure of any origin evaluated after a\n             period of respiratory stabilization (aspiration of secretions, physiotherapy, oxygen\n             and nebulized therapy) when the attending pediatric intensive care physician believes\n             that the patient is  likely to require endotracheal intubation (ETI).\n\n          -  Non intubated\n\n          -  Admitted to the PICU\n\n          -  Minimally agitated/sedated: between -2 and +2  on the Richmond agitation-sedation\n             scale (Table 2)\n\n        Exclusion Criteria:\n\n          1. Patients younger than 1 month or older than 18 year\n\n          2. Patients who need immediate endotracheal intubation: i.e.: Severe ARF with signs of\n             exhaustion\n\n          3. Facial trauma/burns\n\n          4. Recent facial, upper way, or upper gastrointestinal tract surgery  excepting\n             gastrostomy for      feeding\n\n          5. Fixed obstruction of the upper airway\n\n          6. Inability to protect airway\n\n          7. Life threatening hypoxemia defined as SpaO2 <90% with FiO2 > 0.8 on hi-flow oxygen.\n\n          8. Hemodynamic instability: refractory at volume  expansion >60 ml/kg and dopamine >10\n             mcg/kg/min\n\n          9. Impaired consciousness defined as Glasgow coma scale < 10.\n\n         10. Bowel obstruction.\n\n         11. Untreated pneumothorax.\n\n         12. Poor short term prognosis (high risk of death in the next 3 months)\n\n         13. Known esophageal problem (hiatal hernia, esophageal varicosities)\n\n         14. Active upper gastro-intestinal bleeding or any other contraindication to the\n             insertion of a NG tube.\n\n         15. Neuromuscular disease\n\n         16. Vomiting\n\n         17. Cough or gag reflex impairment.\n\n         18. Cyanotic congenital heart disease.\n\n         19. Complete absence of cooperation\n\n         20. This patient has been included (randomized) previously in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "1 Month", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Children from 1 month to 18 years admitted to the PICU with moderate/severe acute\n        respiratory failure minimally sedated/agitated"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01873261", 
            "org_study_id": "HULP-PI-3750"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Neurally Adjusted Ventilatory Assist", 
            "Pediatric Acute Respiratory Failure", 
            "non-invasive ventilation"
        ], 
        "lastchanged_date": "June 7, 2013", 
        "location": {
            "contact": {
                "email": "poliva.hulp@salud.madrid.org", 
                "last_name": "Pedro De la Oliva, MD,PhD", 
                "phone": "0034917277149"
            }, 
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain", 
                    "zip": "28046"
                }, 
                "name": "Hospital Universitario La Paz"
            }, 
            "investigator": {
                "last_name": "Pedro De la Oliva, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "Neurally Adjusted Ventilatory Assist (NAVA) Versus Pressure Support in Pediatric Acute Respiratory Failure - Pilot Study", 
        "overall_contact": {
            "email": "poliva.hulp@salud.madrid.org", 
            "last_name": "Pedro De la Oliva, MD, PhD", 
            "phone": "+347277149"
        }, 
        "overall_official": [
            {
                "affiliation": "Massachusetts General Hospital, Boston, USA", 
                "last_name": "Robert M Kacmarek, PhD RRT FCCM", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Hospital Universitario Dr. Negrin", 
                "last_name": "Jes\u00fas Villar, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ministry of Health and Consumption", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint of this study is avoiding endotracheal intubation (ETI) (and conventional mechanical ventilation (MV)) using non-invasive ventilation (NIV). It is defined as no need for ETI (and MV) for at least 48h after the withdrawal of NIV.", 
            "measure": "Avoiding endotracheal intubation using non-invasive ventilation", 
            "safety_issue": "Yes", 
            "time_frame": "During non invasive ventilation, an average of 2-3 days."
        }, 
        "reference": [
            {
                "PMID": "12667269", 
                "citation": "Cheifetz IM. Invasive and noninvasive pediatric mechanical ventilation. Respir Care. 2003 Apr;48(4):442-53; discussion 453-8. Review."
            }, 
            {
                "citation": "Kendirli T, Kavaz A, Yalaki Z, Ozturk HB, Derelli E, Ince E. Mechanical ventilation in children. Turk J Pediatr 2006;48(4):323-327."
            }, 
            {
                "PMID": "14968216", 
                "citation": "Al-Mutairi SS, Al-Deen JS. Non-invasive positive pressure ventilation in acute respiratory failure. An alternative modality to invasive ventilation at a general hospital. Saudi Med J. 2004 Feb;25(2):190-4."
            }, 
            {
                "PMID": "9827833", 
                "citation": "L'HerE, Moriconi M, Texier F, Bouquin V, Kaba L, Renault A, Garo B, Boles JM. Non-invasive continuous positive airway pressure in acute hypoxaemic respiratory failure--experience of an emergency department. Eur J Emerg Med. 1998 Sep;5(3):313-8."
            }, 
            {
                "PMID": "16276332", 
                "citation": "Bernet V, Hug MI, Frey B. Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure. Pediatr Crit Care Med. 2005 Nov;6(6):660-4."
            }, 
            {
                "PMID": "15599160", 
                "citation": "Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med. 2004 Dec;32(12):2516-23. Review."
            }, 
            {
                "PMID": "18712350", 
                "citation": "Essouri S, Durand P, Chevret L, Haas V, Perot C, Clement A, Devictor D, Fauroux B. Physiological effects of noninvasive positive ventilation during acute moderate hypercapnic respiratory insufficiency in children. Intensive Care Med. 2008 Dec;34(12):2248-55. Epub 2008 Aug 19."
            }, 
            {
                "PMID": "19593246", 
                "citation": "Breatnach C, Conlon NP, Stack M, Healy M, O'Hare BP. A prospective crossover comparison of neurally adjusted ventilatory assist and pressure-support ventilation in a pediatric and neonatal intensive care unit population. Pediatr Crit Care Med. 2010 Jan;11(1):7-11."
            }, 
            {
                "citation": "Biban P, Serra A, Polese G, Soffiati M, Santuz P. Neurally adjusted ventilatory assist: a new approach to mechanically ventilated infants. J Matern Fetal Neonatal Med 2010;23 Suppl 3:38-40.:38-40."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01873261"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Universitario La Paz", 
            "investigator_full_name": "Ignacio Galicia", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Length (days) of endotracheal intubation (conventional mechanical ventilation) after NIV", 
                "safety_issue": "Yes", 
                "time_frame": "During mechanical ventilation after NIV"
            }, 
            {
                "description": "The patients will be follow up after NIV during the PICU stay, and average of two weeks", 
                "measure": "Length (days) of PICU stay after NIV", 
                "safety_issue": "Yes", 
                "time_frame": "After NIV"
            }, 
            {
                "description": "The patients will be follow up after NIV during hospital stay, an average of 2-3 weeks.", 
                "measure": "Length (days) hospital stay after NIV", 
                "safety_issue": "Yes", 
                "time_frame": "After NIV"
            }
        ], 
        "source": "Hospital Universitario La Paz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Universitario La Paz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}